March 26, 2020 / 9:35 PM / 7 days ago

BRIEF-Vir Biotechnology Reports Q4 Revenue Of $1.0 Mln

March 26 (Reuters) - Vir Biotechnology Inc:

* VIR BIOTECHNOLOGY PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* QTRLY LOSS PER SHARE $0.71

* VIR BIOTECHNOLOGY - AS OF DEC 31, 2019, EXCLUDING RESTRICTED CASH, VIR HAD ABOUT $407.7 MILLION IN CASH, CASH EQUIVALENTS, INVESTMENTS

* DUE TO COVID-19 PANDEMIC, CO NOW ANTICIPATES PHASE 1 CLINICAL TRIAL FOR VIR-1111 TO START IN SECOND HALF OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below